Patents by Inventor Todd G. Kirchgessner

Todd G. Kirchgessner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Organic anion transport proteins
    Patent number: 7795392
    Abstract: The current invention discloses nucleic acid and amino acid sequences for novel organic anion transfer proteins (“OATPs”). The invention encompasses the OATPs described herein, together with vectors containing the cDNA sequences, host cells containing the vectors and polypeptides having all or part of an OATP. Also encompasses are uses for OATPs for targeting drugs to specific organs and for modulating the concentration of endogenous substrates.
    Type: Grant
    Filed: May 17, 2007
    Date of Patent: September 14, 2010
    Assignee: Bristol-Myers Squibb Company
    Inventors: Todd G. Kirchgessner, Bonnie Hsiang, Yingjie Zhu, Yuli Wu, Zhaoqing Wang, Jean S. Lynch, Xin Huang, Wen-Pin Yang
  • Organic anion transport proteins
    Patent number: 7235375
    Abstract: The current invention discloses nucleic acid and amino acid sequences for novel organic anion transfer proteins (“OATPs”). The invention encompasses the OATPs described herein, together with vectors containing the cDNA sequences, host cells containing the vectors and polypeptides having all or part of an OATP. Also encompasses are uses for OATPs for targeting drugs to specific organs and for modulating the concentration of endogenous substrates.
    Type: Grant
    Filed: December 16, 2003
    Date of Patent: June 26, 2007
    Assignee: Bristol-Myers Squibb Company
    Inventors: Todd G. Kirchgessner, Bonnie Hsiang, Yingjie Zhu, Yuli Wu, Zhaoging Wang, Jean S. Lynch, Xin Huang, Wen-Pin Yang
  • Novel organic anion transport proteins
    Publication number: 20040132135
    Abstract: The current invention discloses nucleic acid and amino acid sequences for novel organic anion transfer proteins (“OATPs”). The invention encompasses the OATPs described herein, together with vectors containing the cDNA sequences, host cells containing the vectors and polypeptides having all or part of an OATP. Also encompasses are uses for OATPs for targeting drugs to specific organs and for modulating the concentration of endogenous substrates.
    Type: Application
    Filed: December 16, 2003
    Publication date: July 8, 2004
    Inventors: Todd G. Kirchgessner, Bonnie Hsiang, Yingjie Zhu, Yuli Wu, Zhaoging Wang, Jean S. Lynch, Xin Huang, Wen-Pin Yang
  • Organic anion transport proteins
    Patent number: 6692934
    Abstract: The current invention discloses nucleic acid and amino acid sequences for novel organic anion transfer proteins (“OATPs”). The invention encompasses the OATPs described herein, together with vectors containing the cDNA sequences, host cells containing the vectors and polypeptides having all or part of an OATP. Also encompasses are uses for OATPs for targeting drugs to specific organs and for modulating the concentration of endogenous substrates.
    Type: Grant
    Filed: May 19, 2000
    Date of Patent: February 17, 2004
    Assignee: Bristol-Myers Squibb Co.
    Inventors: Todd G. Kirchgessner, Bonnie Hsiang, Yingjie Zhu, Yuli Wu, Zhaoqing Wang, Jean S. Lynch, Xin Huang, Wen-Pin Yang